MoneyWorks4Me

Lupin informs about outcome of board meeting

03 Jun 2021 Evaluate

Lupin has informed that the Board of Directors has approved the Company’s entry into the digital healthcare space with a focus to provide a digital therapeutics platform for doctors and patients in India. The Company recently incorporated a new entity in the name of Lupin Digital Health, as a wholly owned subsidiary, which will undertake this.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..